Latin America Conjugate Vaccine Market is expected togarner USD 5.43 Bn by 2023 with By Major Vendors
Latin America Conjugate Vaccine Market: Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases.
(EMAILWIRE.COM, February 14, 2019 ) Latin America Conjugate Vaccine Market: Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. Latin America is a market with a significant growth rate for conjugate vaccines. The conjugate vaccine market in Latin America is expected to grow at a CAGR of 20.4% leading to revenue of USD 5.43 Bn by 2023. By volume, it is anticipated to reach 839.21 Million units by 2023, expanding at a CAGR of 20.19%.
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/#requestforsample
Countries in the Americas have been among the first few developing nations to introduce pneumococcal conjugate vaccines into their Expanded Programs on Immunization, with 34 countries and territories having introduced these vaccines as of September 2015.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type B, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
o By countries, the Latin American market is divided into Brazil, Argentina and the Rest of LATAM.
Key growth factors:
Latin America has a growing market owing to increase in the incidence of chronic diseases, government initiatives, and control strategies.
Threats and key players:
o The Latin America Conjugate Vaccine market is expected to grow positively. There are still a lot of gaps to be filled for a higher penetration of such vaccines among the masses. A dearth of data on Hib disease burden and limited awareness of Hib disease has resulted in a lack of advocacy for the introduction of Hib vaccine in some countries. Highly complicated manufacturing processes, pricing inefficiencies and lack of accessibility are some of the major obstacles in the growth path, which need to be addressed.
o Conjugate Vaccine providers operating in the market are Pfizer Inc., Merck, Novartis, Sanofi Pasteur, CSL Limited, etc.
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Latin America market overview by revenue
- Latin America historical (2015-2017) market revenue (USD Bn)
- Latin America forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Latin America market overview by volume
- Latin America historical (2015-2017) market volume (Million units)
- Latin America forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Latin America market drivers and challenges
2.4.1. Latin America market drivers
2.4.2. Latin America market challenges
2.5. Latin America market trends
2.6. Value chain
2.7.1. Country-specific market overview Brazil
- Observation
- Key competitors
2.7.1(A) Country-specific market overview Brazil by revenue and by volume
- Brazil historical (2015-2017) market revenue (USD Bn)
- Brazil forecasted (2018-2023) market revenue (USD Bn)
- Brazil historical (2015-2017) market volume (Million units)
- Brazil forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview Argentina
- Observation
- Key competitors
2.7.2(A) Country-specific market overview Argentina by revenue and by volume
- Argentina historical (2015-2017) market revenue (USD Bn)
- Argentina forecasted (2018-2023) market revenue (USD Bn)
- Argentina historical (2015-2017) market volume (Million units)
- Argentina forecasted (2018-2023) market volume (Million units)
2.7.3. Country-specific market overview Rest of LATAM
- Observation
- Key competitors
2.7.3(A) Country-specific market overview Rest of LATAM by revenue and by volume
- Rest of LATAM historical (2015-2017) market revenue (USD Bn)
- Rest of LATAM forecasted (2018-2023) market revenue (USD Bn)
- Rest of LATAM historical (2015-2017) market volume (Million units)
- Rest of LATAM forecasted (2018-2023) market volume (Million units)
Chapter 3: Latin America major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal Latin America (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib Latin America (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP Latin America (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal Latin America (USD Bn, Million units)
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Download Free Report Sample (PDF) Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/#requestforsample
Countries in the Americas have been among the first few developing nations to introduce pneumococcal conjugate vaccines into their Expanded Programs on Immunization, with 34 countries and territories having introduced these vaccines as of September 2015.
Market Segmentation:
o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type B, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
o By countries, the Latin American market is divided into Brazil, Argentina and the Rest of LATAM.
Key growth factors:
Latin America has a growing market owing to increase in the incidence of chronic diseases, government initiatives, and control strategies.
Threats and key players:
o The Latin America Conjugate Vaccine market is expected to grow positively. There are still a lot of gaps to be filled for a higher penetration of such vaccines among the masses. A dearth of data on Hib disease burden and limited awareness of Hib disease has resulted in a lack of advocacy for the introduction of Hib vaccine in some countries. Highly complicated manufacturing processes, pricing inefficiencies and lack of accessibility are some of the major obstacles in the growth path, which need to be addressed.
o Conjugate Vaccine providers operating in the market are Pfizer Inc., Merck, Novartis, Sanofi Pasteur, CSL Limited, etc.
Get Discount & Customization of this Report Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/
Table Of Content
Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II
Chapter 2: Market overview
2.1. Market definitions
2.2. Latin America market overview by revenue
- Latin America historical (2015-2017) market revenue (USD Bn)
- Latin America forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Latin America market overview by volume
- Latin America historical (2015-2017) market volume (Million units)
- Latin America forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Latin America market drivers and challenges
2.4.1. Latin America market drivers
2.4.2. Latin America market challenges
2.5. Latin America market trends
2.6. Value chain
2.7.1. Country-specific market overview Brazil
- Observation
- Key competitors
2.7.1(A) Country-specific market overview Brazil by revenue and by volume
- Brazil historical (2015-2017) market revenue (USD Bn)
- Brazil forecasted (2018-2023) market revenue (USD Bn)
- Brazil historical (2015-2017) market volume (Million units)
- Brazil forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview Argentina
- Observation
- Key competitors
2.7.2(A) Country-specific market overview Argentina by revenue and by volume
- Argentina historical (2015-2017) market revenue (USD Bn)
- Argentina forecasted (2018-2023) market revenue (USD Bn)
- Argentina historical (2015-2017) market volume (Million units)
- Argentina forecasted (2018-2023) market volume (Million units)
2.7.3. Country-specific market overview Rest of LATAM
- Observation
- Key competitors
2.7.3(A) Country-specific market overview Rest of LATAM by revenue and by volume
- Rest of LATAM historical (2015-2017) market revenue (USD Bn)
- Rest of LATAM forecasted (2018-2023) market revenue (USD Bn)
- Rest of LATAM historical (2015-2017) market volume (Million units)
- Rest of LATAM forecasted (2018-2023) market volume (Million units)
Chapter 3: Latin America major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal Latin America (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib Latin America (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP Latin America (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal Latin America (USD Bn, Million units)
.....
Get Complete TOC with Figures and Tables Here:https://www.researchreporthub.com/report/latin-america-conjugate-vaccine-market/11304/#toc
Research Report Hub
Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub
Sector 04, Plot 101, Sant Nagar,
Moshi PCNDTA, Pune, 412105
Maharashtra, India
Web:www.researchreporthub.com
Find us on: <||>rnhttps://www.facebook.com/reasearchreporthub/ <||>rnhttps://twitter.com/hub_report <||>rnhttps://www.linkedin.com/company/research-report-hub/
Contact Information:
Research Report Hub
Prakriti Mathur
Tel: +918448444687
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Report Hub
Prakriti Mathur
Tel: +918448444687
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results